Videos

The FDA held a day-long meeting on Emergency Use Authorization (EUA) for Moderna’s COVID-19 vaccine. Presentations from the FDA and Moderna addressed issues such as allergic reactions and Be…

The Food and Drug Administration held a virtual open meeting to discuss Moderna’s COVID-19 vaccine and whether it should be recommended for emergency use authorization. Members of the Vaccin…

The Food and Drug Administration hosted a virtual open meeting to discuss Pfizer-BioNTech COVID-19 vaccine and Emergency Use Authorization (EUA). Members of the Vaccines and Related Biologic…

After a two-day joint meeting, the FDA Nonprescription Drugs and Pediatric Advisory Committees recommended a ban on the use of over-the-counter cough and cold products for children under six…

The acting Commissioner addressed an FDA Science Forum celebrating the agency’s 100th anniversary. His topic was, “Creating the FDA for the 21st Century.” He talked about the history of the…

This is the last day of a joint meeting of the FDA’s Arthritis and Drug Safety and Risk Management Advisory Committees. At the end of the three-day forum the 32-member panel had recommended …

At a joint meeting of the Arthritis and Drug Safety and Risk Management Advisory Committees, experts discussed the safety of arthritis drugs called “COX-2” inhibitors. Dr. Anne Trontell gave…

At a joint meeting of the Arthritis and Drug Safety and Risk Management Advisory Committees, members discussed the safety of drugs called “COX-2” inhibitors, such as Vioxx and Celebrex. Dr. …

The Food and Drug Administration’s Arthritis and Drug Safety and Risk Management Advisory Committees continued discussions in their joint meeting on possible safety of risks of “COX-2” inhib…

Committee members heard public comments made by representatives of arthritis-related and consumer organizations, as well as the general public, on the safety of various medications designed …

Physicians spoke at a meeting to assess the safety records of arthritis drugs. Representatives for the drug Lumiracoxib and for the Food and Drug Administration spoke. They also responded to…

Physicians spoke at a meeting to assess the safety records of arthritis drugs. Representatives for the drug Arcoxia and for the Food and Drug Administration spoke about a number of issues in…

Physicians spoke at a meeting to assess the safety records of arthritis drugs such as Vioxx and Celebrex. They also talked about recent uses of the class of drugs, the medical and scientific…

Dr. Villalba and others spoke at a meeting to assess the safety records of arthritis drugs. They talked about testing and approval of the drug Vioxx and its subsequent use by American consum…

Physicians spoke at a meeting to assess the safety records of arthritis drugs. Representatives for the drugs Celebrex, Bextra, Parecoxib, and Naproxen spoke as did representatives for the Fo…

A joint meeting of the Food and Drug Administration’s Arthritis and Drug Safety and Risk Management Advisory Committees held a forum on the safety of “COX-2” inhibitors. The function of the …

Participants talked about prevention methods in place throughout the Food and Drug Administration to keep Mad Cow disease out of the United States. They focused on inspections, enforcement o…

A variety of industry representatives and issue advocates testified on the issue of birth control availability. Some wish to make birth control pills and “morning after” pills over the count…

Health experts and industry lobbyists debated the extent to which prescription drugs should be converted to “over the counter” status. They also talked about the sometimes blurry line betwee…